Back to All Funded Projects
2026 Award Graduation Project Capacity Building & Enhanced Experimental Support Grant Egypt

New Horizons in Pharmaceutical Innovation: UKABCS Congratulates Pharos University on Winning the 2026 Graduation Project Grant & Welcomes Them to the UKABCS Family!

Lead Institution: Pharos University in Alexandria (Egypt)

Empowering pharmacy graduates with Computer-Aided Drug Design (CADD), molecular docking simulations, and wet-lab pharmacological assay support.

New Horizons in Pharmaceutical Innovation: UKABCS Congratulates Pharos University on Winning the 2026 Graduation Project Grant & Welcomes Them to the UKABCS Family!

Grantor: UK Organisation for Biotechnology and Computational Science (UKABCS)
Awarded Institution: Pharos University in Alexandria — Faculty of Pharmacy
Main Principal Investigator (Main PI): Assoc. Prof. Nesrine Saeid El-Mezayen (Department of Pharmacology and Therapeutics)
Application ID: GR2612
Article Type: Official Press Release & Congratulatory Website Article
Approval Date: August 19, 2026


1. Official Announcement & Heartfelt Congratulations

The UK Organisation for Biotechnology and Computational Science (UKABCS) extends its warmest congratulations to Pharos University in Alexandria — Faculty of Pharmacy on winning the UKABCS Graduation Project Capacity Building & Enhanced Experimental Support Grant 2026 (Application ID GR2612).

This scientific award honors the Faculty of Pharmacy at Pharos University for its exceptional dedication to pharmaceutical discovery, computer-aided drug design, and translational pharmacological research.


2. Student Capacity & Scale of Impact

The 2026 grant provides comprehensive academic and laboratory support for pharmacy graduates in Alexandria:

  • Awarded Research Teams: Full capacity support for participating graduation project teams at the Faculty of Pharmacy.
  • Participating Cohort: Capacity building for undergraduate pharmacy students across the 3-year grant cycle (2026–2029).
  • Scientific Focus: Pharmacology, Therapeutics, Computer-Aided Drug Design (CADD), and Molecular Docking.

3. Dual-Phase Capacity Building Framework

Participating pharmacy teams will undertake a specialized research journey governed by the UKABCS Dual-Phase Framework:

Phase I: Capacity Building & Computational Training

  • Full Platform Access: Provision of credentials to UKABCS digital suites, drug simulation pipelines, and databases.
  • Specialized Training: Intensive coursework in Computer-Aided Drug Design (CADD), Virtual Screening of ligand libraries, and protein-ligand docking.

Phase II: Project Execution & Experimental Validation

  • Wet-Lab Validation: Practical laboratory support for pharmacological evaluation and experimental assay validation.
  • Publication Mentorship: Academic guidance for drafting, refining, and publishing research papers in peer-reviewed pharmaceutical journals.

4. Enhanced Experimental Support & Chemical Cash Fund

To support practical laboratory synthesis and pharmacological testing, UKABCS has introduced an enhanced experimental funding track:

  • Annual Chemical & Reagents Allocation: A dedicated cash funding enhancement of £3,000 GBP per year allocated exclusively for purchasing approved Kits & Reagents and pharmaceutical consumables for winning project teams.
  • Total Experimental Funding: Reaches £9,000 GBP across the 3-year grant cycle.
  • Direct Supplier Disbursement: Procurement payments are disbursed directly by UKABCS to verified chemical suppliers via the Lab Chem Flow platform.

5. Main PI Leadership (Assoc. Prof. Nesrine Saeid El-Mezayen) & Governance

Assoc. Prof. Nesrine Saeid El-Mezayen (Department of Pharmacology and Therapeutics) serves as the designated Main Principal Investigator (Main PI). Under Clause 10.1 of the agreement, her leadership encompasses:

  • Scientific Review & Specification Approval: Evaluating and approving technical specifications for Kits & Reagents submitted by research teams.
  • Digital Management via Lab Chem Flow: Overseeing procurement requests, inventory checks, and chemical dispensing through Lab Chem Flow.
  • Resource Consolidation: Managing shared chemical utilization among pharmacy project teams to maximize research efficiency.
  • Reporting & Publication Governance: Submitting Quarterly Progress Reports and Annual Institutional Reports to UKABCS while maintaining institutional attribution for Pharos University and UKABCS.

6. Welcome to the UKABCS Family!

The UK Organisation for Biotechnology and Computational Science (UKABCS) is delighted to officially welcome Pharos University in Alexandria (Faculty of Pharmacy), its faculty, Assoc. Prof. Nesrine El-Mezayen, and pharmacy students into the global UKABCS Family.

We are immensely proud of this collaboration in Alexandria and look forward to celebrating your scientific breakthroughs. Welcome to your UKABCS Family!

Want to Apply for UKABCS Project Funding?

Discover application terms, eligibility criteria, and open grant windows for early-career and established researchers.